A new series of N6,5'-bis-ureido-5'-amino-5'-deoxyadenosine derivatives was prepared and evaluated for anticancer activities using the NCI 60 panel of human cancers. Certain of the derivatives showed promising activities (low micromolar GI50's) against several of the representative cancers. These included cell lines from the following general cell types in the NCI 60: Leukemia, Breast, Central Nervous System, Non-Small Cell Lung, Ovarian, Prostate, Renal, and Colon cancers. Select compounds were also screened for their affinities for protein kinases. The synthesis of the compounds was straightforward and involved N6 acylation with arylisocyanates, preceded by activation and nucleophilic substitution of the 5'-position to give the desired 5'-azido-5'-deoxyadenosine derivatives. Reduction of the 5'-azido function with either H2/Pd-C, or Ph3P/H2O, gave the desired 5'-amino-5' deoxyadenosine products. Acylation of the 5'-amino group with N-methyl 4-nitrophenylcarbamate gave the N6,5'-bis-ureido-5'-amino-5' deoxyadenosine products. Yields ranged from good (50–75%) to excellent (75–95%) for all synthetic transformations.

No description available.

Cette thèse s’articule autour de systèmes innovants de délivrance d’anticancéreux pour répondre aux limitations actuelles des systèmes de type nanoparticules. Celles-ci permettent l’encapsulation d’anticancéreux pour prolonger leur temps de circulation dans le sang et diminuer leurs effets secondaires. Néanmoins les produits disponibles en cliniques ne permettent pas un contrôle précis de la libération de la substance active, ni un ciblage de la tumeur.Pour répondre à ces deux limitations, nous avons synthétisé un copolymère thermosensible ayant une température critique haute de solubilité (upper critical solution temperature, UCST) pour formuler des nanoparticules encapsulant physiquement la doxorubicine. Celles-ci permettent la libération contrôlée de la substance active par hyperthermie modérée à 43 °C. Nous avons étudié notre système d’un point de vue physico-chimique et évalué sa cytotoxicité in vitro sur des cellules de cancer de l’ovaire.Nous avons également opté pour une approche via couplage chimique entre une substance active, le paclitaxel, et le polymère afin de permettre l’administration par la voie sous-cutanée d’anticancéreux. En effet, cette voie d’administration est peu utilisée pour les anticancéreux car certains d’entre eux induisent une toxicité locale au site d’injection de type irritation / nécrose de la peau. Nous avons évalué si d’une part, l’approche prodrogue polymère hydrophile permet d’empêcher cette toxicité locale et si d’autre part, l’approche prodrogue polymère UCST permet d’obtenir des nanoparticules stables à température ambiante en vue d’une administration par la voie sous-cutanée. Une fois administrées, les nanoparticules deviennent hydrophiles par le changement de température, 34 °C dans le tissu sous-cutané, et peuvent donc diffuser librement jusqu’à atteindre la circulation sanguine. Nos travaux ont permis d’évaluer l’approche prodrogue polymère hydrophile in vivo chez la souris nude, ainsi que de décrire pour la première fois la synthèse de prodrogues polymères UCST. / This thesis focuses on innovative drug delivery systems of anticancer drugs to tackle the current limitations of formulations based on nanoparticles. These allow encapsulation of anticancer drugs to prolong their circulation time in the blood stream and to decrease side effects. Yet, nanoparticle formulations available in the clinic do not allow a precise control on the drug release nor targeting of the tumor.To overcome these hurdles, we have synthesized a thermoresponsive copolymer exhibiting an upper critical solution temperature (UCST) to formulate nanoparticles physically encapsulating doxorubicin. These allow controlled release of the anticancer drug by mild hyperthermia at 43 °C. We have studied our system from a physico-chemical point of view and evaluated its cytotoxicity in vitro on ovarian cancer cells.We have also tried a chemical coupling approach between the polymer and the anticancer drug, paclitaxel, to allow innocuous subcutaneous administration. In did, this route of administration is seldom used for anticancer drugs as some of them induce local toxicity at the site of injection in the form of skin irritation / necrosis. We assessed if a hydrophilic polymer prodrug approach allows innocuous subcutaneous administration of an irritant drug; and if a UCST polymer prodrug approach enables formation of stable nanoparticles at room temperature for subcutaneous administration. Once in the subcutaneous tissue at 34 °C, they would solubilize and become hydrophilic thus could freely diffuse to reach the blood circulation. We have managed to evaluate the hydrophilic polymer prodrug approach in vivo on nude mice and we are the first to describe the synthesis of UCST polymer prodrug.

京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第18221号 / 薬科博第25号 / 新制||薬科||4(附属図書館) / 31079 / 京都大学大学院薬学研究科医薬創成情報科学専攻 / (主査)教授 掛谷 秀昭, 教授 高須 清誠, 准教授 大野 浩章 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第20312号 / 薬科博第81号 / 新制||薬科||9(附属図書館) / 京都大学大学院薬学研究科医薬創成情報科学専攻 / (主査)教授 大野 浩章, 教授 高須 清誠, 教授 竹本 佳司 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(農学) / 甲第21153号 / 農博第2279号 / 新制||農||1059(附属図書館) / 学位論文||H30||N5127(農学部図書室) / 京都大学大学院農学研究科食品生物科学専攻 / (主査)教授 入江 一浩, 教授 保川 清, 教授 橋本 渉 / 学位規則第4条第1項該当 / Doctor of Agricultural Science / Kyoto University / DFAM

No description available.

No description available.

4’ -ester analogues of resveratrol were synthesized using reaction conditions developed to produce mono-ester products in the presence of two other unprotected phenols. Basic conditions were employed to deprotonate the most acidic 4’ phenol followed by addition of anhydrides or acid chlorides to give the ester product. The reaction favored 4’-ester formation in polar aprotic solvents with DMSO being the optimal solvent. (—)-Englerin A is a guaiane-type sesquiterpene containing two ester side chains. Mimics of (—)-englerin A were proposed that retained the ester side chains while replacing the non-polar core with less complicated structures. These proposed mimic cores would maintain the three-dimensional positioning of the esters which are responsible for the anti-cancer activity of (—)-englerin A. Three mimics were synthesized using the bicyclic terpenes borneol and fenchol. Installation of the second ester on the terpene core was accomplished throught the development and optimization of a unique methylene oxidation using chromium trioxide in glacial acetic acid. These mimics were screened against two kidney cancer cell lines. The compounds were shown to have IC50 (inhibitory concentration for 50 % of cells) values above 30 µM.

The full text will be available at the end of the embargo period: 28th March 2027